Home > Insider Trading > Filing (0001209191-20-054733)

Filing Details

Accession Number:: 0001209191-20-054733
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-13 19:04:46
Reporting Period:: 2020-10-09

Accepted Time:: 2020-10-13 19:04:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1468748	Kodiak Sciences Inc.	KOD	Biological Products, (No Disgnostic Substances) (2836)	270476525

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754049	Jason Ehrlich	2631 Hanover Street Palo Alto CA 94304	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-10-09	15,000	$0.00	48,984	No	4	M	Direct
Common Stock	Disposition	2020-10-09	3,941	$71.25	45,043	No	4	F	Direct
Common Stock	Disposition	2020-10-09	553	$69.91	44,490	No	4	S	Direct
Common Stock	Disposition	2020-10-09	751	$71.27	43,739	No	4	S	Direct
Common Stock	Disposition	2020-10-09	896	$72.14	42,843	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-10-09	15,000	$0.00	15,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of 25% of the Reporting Person's restricted stock units granted on October 9, 2018. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These sales were made to cover tax withholding obligations in connection with vesting and settlement of 25% of the Reporting Person's RSU granted on October 9, 2018.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $69.65 to $70.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $70.88 to $71.705, inclusive.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $71.91 to $72.57, inclusive.
50% of the RSU vested 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSU vested 18 months after the Grant Date and 25% of the RSU vest 24 months after the Grant Date.